Research lacking on medical pot, ample evidence of harms: doctors' groups
- Thread starter WHATFG
- Start date
WHATFG
Well-Known Member
The decision to use cannabis for medical purposes is one that is made between patients and their health-care practitioners, and does not involve Health Canada," department spokeswoman Tammy Jarbeau said Tuesday in an email.
Then why do patients have to register?
The research likely underestimates the frequency of adverse outcomes because most studies involve patients who have a history of using pot so are less likely than the average person to experience any negative side effects, Allan said.
Now read that again...lol..."patients who have a history of using pot so are less likely than the average person to experience any negative side effects."
Some of the pain studies go for nothing more ... than five, six hours. And this is for chronic pain," Allan said. "It's hard to get a great feel for how someone is going to do long term on a medicine after five, six hours."
But they'll "try" all kinds of pharma until they get a good combo with minimal side effects...why doesn't it surprise me this shit is coming from the AB college?
Then why do patients have to register?
The research likely underestimates the frequency of adverse outcomes because most studies involve patients who have a history of using pot so are less likely than the average person to experience any negative side effects, Allan said.
Now read that again...lol..."patients who have a history of using pot so are less likely than the average person to experience any negative side effects."
Some of the pain studies go for nothing more ... than five, six hours. And this is for chronic pain," Allan said. "It's hard to get a great feel for how someone is going to do long term on a medicine after five, six hours."
But they'll "try" all kinds of pharma until they get a good combo with minimal side effects...why doesn't it surprise me this shit is coming from the AB college?
VIANARCHRIS
Well-Known Member
Well looky here, an American fact based report released this year that says the complete opposite.....
https://www.nap.edu/read/24625/chapter/1
https://www.nap.edu/read/24625/chapter/1
VIANARCHRIS
Well-Known Member
CHRONIC PAIN
Relief from chronic pain is by far the most common condition cited by patients for the medical use of cannabis. For example, Light et al. (2014)reported that 94 percent of Colorado medical marijuana ID cardholders indicated “severe pain” as a medical condition. Likewise, Ilgen et al. (2013)reported that 87 percent of participants in their study were seeking medical marijuana for pain relief. In addition, there is evidence that some individuals are replacing the use of conventional pain medications (e.g., opiates) with cannabis. For example, one recent study reported survey data from patrons of a Michigan medical marijuana dispensary suggesting that medical cannabis use in pain patients was associated with a 64 percent reduction in opioid use (Boehnke et al., 2016). Similarly, recent analyses of prescription data from Medicare Part D enrollees in states with medical access to cannabis suggest a significant reduction in the prescription of conventional pain medications (Bradford and Bradford, 2016). Combined with the survey data suggesting that pain is one of the primary reasons for the use of medical cannabis, these recent reports sug-
CANCER
Cancer is a broad term used to describe a wide range of related diseases that are characterized by an abnormal, unregulated division of cells; it is a biological disorder that often results in tumor growth (NCI, 2015). Cancer is among the leading causes of mortality in the United States, and by the close of 2016 there will be an estimated 1.7 million new cancer diagnoses (NCI, 2016). Relevant to the committee’s interest, there is evidence to suggest that cannabinoids (and the endocannabinoid system more generally) may play a role in the cancer regulation processes (Rocha et al., 2014). Therefore, there is interest in determining the efficacy of cannabis or cannabinoids for the treatment of cancer.
DEPRESSION
Depression is one of the nation’s most common mental health disorders (ADAA, 2016). Across the many depressive disorders that exist (e.g., persistent depressive disorder, major depressive disorder, premenstrual dysphoric disorder) there are common symptomatic features of feelings of sadness, emptiness, or irritable mood, accompanied by somatic and cognitive changes that affect the individual’s capacity to function (APA, 2013, p. 155). The endocannabinoid system is known to play a role in mood regulation (NIDA, 2015, p. 9); therefore, the committee decided to explore the association between cannabis use and depressive disorders or symptoms.
Relief from chronic pain is by far the most common condition cited by patients for the medical use of cannabis. For example, Light et al. (2014)reported that 94 percent of Colorado medical marijuana ID cardholders indicated “severe pain” as a medical condition. Likewise, Ilgen et al. (2013)reported that 87 percent of participants in their study were seeking medical marijuana for pain relief. In addition, there is evidence that some individuals are replacing the use of conventional pain medications (e.g., opiates) with cannabis. For example, one recent study reported survey data from patrons of a Michigan medical marijuana dispensary suggesting that medical cannabis use in pain patients was associated with a 64 percent reduction in opioid use (Boehnke et al., 2016). Similarly, recent analyses of prescription data from Medicare Part D enrollees in states with medical access to cannabis suggest a significant reduction in the prescription of conventional pain medications (Bradford and Bradford, 2016). Combined with the survey data suggesting that pain is one of the primary reasons for the use of medical cannabis, these recent reports sug-
CANCER
Cancer is a broad term used to describe a wide range of related diseases that are characterized by an abnormal, unregulated division of cells; it is a biological disorder that often results in tumor growth (NCI, 2015). Cancer is among the leading causes of mortality in the United States, and by the close of 2016 there will be an estimated 1.7 million new cancer diagnoses (NCI, 2016). Relevant to the committee’s interest, there is evidence to suggest that cannabinoids (and the endocannabinoid system more generally) may play a role in the cancer regulation processes (Rocha et al., 2014). Therefore, there is interest in determining the efficacy of cannabis or cannabinoids for the treatment of cancer.
DEPRESSION
Depression is one of the nation’s most common mental health disorders (ADAA, 2016). Across the many depressive disorders that exist (e.g., persistent depressive disorder, major depressive disorder, premenstrual dysphoric disorder) there are common symptomatic features of feelings of sadness, emptiness, or irritable mood, accompanied by somatic and cognitive changes that affect the individual’s capacity to function (APA, 2013, p. 155). The endocannabinoid system is known to play a role in mood regulation (NIDA, 2015, p. 9); therefore, the committee decided to explore the association between cannabis use and depressive disorders or symptoms.
Anothermeduser
Well-Known Member
The college mearly makes suggestions, i had called them at a few locations about there bullshit suggestion of not over 1 gram, had to point out to my doctor that its mearly suggestions and quote health canada "no limit". The college is a bad joke, those guys need a real job
VIANARCHRIS
Well-Known Member
Their main job is working for big pharma. They need a bullet.
Cursed works well too
